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Background: Many published epidemiologic studies confirm a marked increase in the prevalence of asthma and
allergic rhinitis. The link between allergic rhinitis and asthma has been extensively studied and approximately 75%
of patients with asthma have allergic rhinitis. The proportion of patients with asthma in populations of allergic
rhinitis patients has not been well studied.
Objective: The purpose of this study is to estimate the prevalence of undiagnosed asthma in a specific population
of patients presenting to an Otolaryngologist with symptoms of allergic rhinitis.
Study design: Prospective cohort study. Methods: Patients presenting with symptoms of allergic rhinitis to two
tertiary care Rhinology practices in Northern Alberta were asked to undergo allergy skin testing, serum IgE
quantification, and pulmonary functional testing. Patients with previous asthma screening or known history of
reactive airway disease or asthma were excluded.
Results: 107 patients with allergic rhinitis symptoms were recruited between September 2010 to January 2013.
Patients predominantly had perennial or persistent rhinitis (64.5%) with moderate-severe symptoms (50.5%). While
only 14.9% of patients had abnormal IgE levels, 68.8% had positive skin testing. Abnormal pulmonary function tests
were obtained in 39.1% of patients and 26.1% of patients were diagnosed with asthma.
Conclusions: There is a high prevalence of undiagnosed asthma in patients presenting to tertiary Rhinology care
with moderate to severe allergic rhinitis symptoms. Screening lung function testing should be considered in this
patient population.Introduction
Many published epidemiologic studies examining popu-
lations in Europe over the last few decades have con-
firmed a marked increase in the prevalence of asthma
and allergic rhinitis [1-3]. One recently published study
estimates that the overall prevalence of allergic rhinitis
in the Canadian population is 20% with a high burden of
disease, including limitations on lifestyle and poor symp-
tom control [4]. Similarly, overall prevalence of asthma
remains high in Canada. Direct costs of managing this
chronic condition is increasing and it remains the num-
ber one cause of decreased productivity and missed
work days [5]. The link between allergic rhinitis and
asthma has been extensively studied [6]. Approximately
75% of patients with asthma have allergic rhinitis [7].* Correspondence: caroline.xu@ualberta.ca
1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery,
University of Alberta, 8440 112 Street, Edmonton, Alberta T6G 2B7, Canada
Full list of author information is available at the end of the article
© 2013 Jeffery et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orThe proportion of patients with asthma in populations
of allergic rhinitis patients has not been well studied,
with small studies reporting ranges between 10 to 40% and
no studies looking at this proportion in the Canadian popu-
lations [7-9]. Studies have also shown that allergic rhinitis
has a major impact on asthma morbidity and that treating
allergic rhinitis may also impact asthma control [10].
Several explanations for this close relationship prevail
in the literature. At the forefront is the unified airway
hypothesis, which states that both upper and lower
airway allergic symptoms are manifestations of the same
atopic disease [11]. Asthma and rhinitis share many
pathophysiologic characteristics [12] and studies suggest
that subclinical allergic inflammation is present in the
lower airway of patients with allergic rhinitis [13].
Clinically, both allergic rhinitis and asthma are triggered
by many of the same environmental allergens [14]. Fur-
thermore, it is proposed that a loss of nasal function,
presence of a nasobronchial reflex, and propagation ofLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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also contribute to combined nasal and airway inflam-
mation [15].
The current understanding of shared pathophysiology
between allergic rhinitis and asthma prompted the
World Health Organization’s ARIA (Allergic Rhinitis
and its Impact on Asthma) to recommend asthma
screening in patients with allergic rhinitis. Nonetheless,
it is not current practice by most Otolaryngology-
Rhinology practitioners in Canada to order this screen-
ing routinely for patients with symptoms consistent
with allergic rhinitis. The purpose of this cross-
sectional study is to estimate the prevalence of undiag-
nosed asthma in a specific population of patients
presenting to an Otolaryngologist with symptoms of









Seasonal AR 39 36.4%
Perennial AR 64 59.8%
Intermittent 38 51.4%
Persistent 69 64.5%







Prior Sinonasal Surgery 7 6.5%
ASA Insensitivity 5 4.7%
Recent oral corticosteroid 3 2.8%
Atopic History Family history of Atopy 46 43.0%






University of Alberta Research Ethics Board approval was
obtained prior to commencement of study (Pro00032514).
Adult patients (age ≥ 17 years of age) presenting to two
Academic Otolaryngologists with rhinology practices at the
University of Alberta with one or more symptoms of rhin-
itis were prospectively recruited between September 2010
and January 2013. Patients were diagnosed with allergic
rhinitis if at least one symptom of nasal itching, sneezing,
nasal obstruction, congestion, rhinorrhea, and/or hyposmia
was present in association allergen exposure. Patients with
concomitant diagnosis of chronic rhinosinusitis with or
without polyposis were not excluded. Patients with known
or previously diagnosed allergic asthma or reactive airway
disease were excluded.
Severities of nasal symptoms were categorized
as intermittent versus persistent and mild versus
moderate-severe in accordance with the WHO Allergic
Rhinitis and its Impact on Asthma 2008 Guidelines
[http://www.whiar.org/Documents&Resources.php]. A
four-point asthma-screening tool was also adminis-
tered to each patient (Table 1). Recruited patients sub-
sequently underwent skin-prick specific IgE allergy
testing, total serum IgE quantification, and pulmonary
function testing. Diagnosis of asthma was based on
demonstration of reversible airway obstruction with bron-
chodilator administration as indicated by ≥12% increase in
FVC (forced vital capacity) or FEV1 (forced expiratory
volume in one second). Severity of asthma on pulmonary
function testing was classified by FEV1/FVC ratio ac-
cording to standard ranges (http://www.ginasthma.
org/). All data recorded were compared to norms
based on age, gender, race, weight and height. All
patients underwent testing at the same diagnostic
laboratory. Results of testing were prospectively col-
lected in a database.Risk factor analysis
SPSS 20.0 was used for statistical analysis. Factors were
examined for association with increased likelihood of
asthma using Mantel-Haenszel tests followed by regres-
sion analysis using likelihood ratio tests. A significance
level of p < 0.05 was used for all analysis.
Results
One hundred and seven patients were recruited dur-
ing the study period (Figure 1 and Table 1). The ma-
jority of patients had persistent and moderate-severe
symptoms of allergic rhinitis (Table 1) and 17.8% of
patients had clinical and/or radiographic evidence of
chronic rhinosinusitis with or without polyposis.
Almost 87% of patients responded “yes” to two or
more questions from the Asthma Screening Tool
(Figure 2).
IgE-allergy skin testing
68.8% of patients had positive IgE-specific skin testing
(Table 2). On average, patients were sensitized to 3.5 al-
lergens (Range 1 to 20). 20.0% of patients had negative
skin-prick testing despite a history of environmental
allergies.
Pulmonary function testing
92 patients underwent pulmonary function testing with
abnormalities found in 36 patients (39.1%). Of the
abnormal results, 24 patients had a diagnosis of
Figure 1 Patient recruitment and attrition.
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‘Methods’. The distribution of severity of asthma is
shown in Table 3.Risk factor analysis
Regression analysis failed to show any independent
risk factors for increased risk of asthma diagnosis
(Table 4).Figure 2 Distribution of responses to asthma screening tool.Discussion
This study found a high rate of undiagnosed asthma
in a population of patients with allergic rhinitis pre-
senting to tertiary care Rhinology in Northern Alberta.
The results of this study support the existing evidence
for a strong association between asthma and allergic
rhinitis. It also supports studies that have
demonstrated AR as an independent risk factor for
asthma [7].
To our knowledge, there are currently no other stud-
ies in the literature that examine the rate of undiag-
nosed asthma in allergic rhinitis patients. Also, no
studies have examined, specifically, the value of asthma
screening in this population despite recent ARIA
guidelines, which recommended that persistent allergic
rhinitis should be evaluated for asthma [16]. We found
that 26.1% of patients in our cohort had asthma on
pulmonary function testing. Majority of patients in our
cohort were subsequently referred to Pulmonary
Medicine for further management of their lower-
airway disease. Although not all patients required
immediate initiation of medical management, earlier
detection of asthma potentially facilitates patient coun-
seling and long-term management of their disease. In
addition, substantial literature exists that demonstrate
benefits of managing AR in patients with co-morbid
asthma [17].
Our study failed to identify any specific risk factors for
abnormal pulmonary function test results in patients
with allergic rhinitis. Specifically, a family history of
atopy, positive allergy skin testing and answers to the 4-
point allergy-screening tool failed to predict likelihood
of asthma. Some authors have suggested that a serum
IgE level > 140 IU/ml may be predictive of atopic disease
[18], while others have suggested lower limits or even
limited utility [19, 20]. At our institution, a total IgE of










Positive Skin-prick Testing 66 (68.8 %)
Average No. of Allergens
Sensitized
3.5 ± 2.4
Table 4 Mantel-Hanzel odds ratio estimates of various





Male Sex 1.711 0.667 – 4.376 0.263
Type of AR Seasonal 0.758 0.492 – 4.076 0.573
Perennial 0.875 0.290 – 1.984 0.779
Intermittent 1.296 0.345 – 2.220 0.596
Persistent 0.786 0.500 – 3.360 0.632
Mild 1.726 0.303 – 2.040 0.252
Moderate-Severe 0.627 0.678 – 4.396 0.324
Sinonasal Disease CRS 0.645 0.238 – 1.584 0.387





0.900 0.266 – 1.944 0.866
3 or More “Yes” to Asthma
Sreening tool
1.191 0.465 – 3.049 0.480
Atopic History Family History 0.759 0.296 – 1.944 0.565
Atopic Dermatitis 0.656 0.198 – 2.168 0.489
Subjective
Allergies
1.013 0.328 – 3.134 0.982
Positive Skin
Testing
1.417 0.492 – 4.076 0.518
Abnormal IgE 2.667 0.735 – 9.669 0.136
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finding in our patients, while yielding an Odds Ratio of
2.667 with findings of asthma on PFT, failed to reach
statistical significance. Further studies are necessary
to examine other potential risk factors for increased
likelihood asthma in AR patients such as duration of
allergic rhinitis, geography, and respiratory sensitizer
exposure.
Admittedly, this is a cross-sectional study with a
relatively small sampling of patients in Alberta and
is highly selected – the patients in our study had sig-
nificant nasal complaints as demonstrated by a high
proportion of patients with moderate-severe (50.5%)
and persistent rhinitis (64.5%). This is in contrast to
the mild symptoms seen in the general population who
are likely managed by primary care practitioners [21].
In addition, the study patients would benefit from ob-
servation for longer periods of time. It is possible that
patients with initially normal PFTs may subsequently
develop evidence of lower airway disease if followed
over time. Finally, the overall prevalence of asthma in
Canada varies between 5 and 10%, with Alberta report-
ing the highest rates in Canada of up to 10.2% [22, 23].Table 3 Results of pulmonary function testing
Number of
patients (%)
Underwent PFT 92 (100%)





Restrictive lung disease or
chest wall abnormality
5 (5.4%)
Diffusion abnormalities 2 (2.2%)
Other 5 (5.2%)Thus, the results of our study may not be applicable to
other regions. Similar studies from other centers in
Canada would help clarify this question.
Despite these limitations, the results of this study
remain useful to clinicians that treat patients with a
spectrum of AR severity. It reinforces the fact that
AR is not a trivial disease and should be man-
aged aggressively to optimize progression of airway
reactivity. In patients with persistent and severe
disease, there is a high rate of undiagnosed, but clin-
ically significant asthma and we feel this warrants
consideration for increased asthma screening by
practitioners who see allergic rhinitis patients. Future
studies examining the cost-effectiveness of asthma
screening in this population are necessary before
widespread adoption.Conclusions
There is a high prevalence of undiagnosed asthma in
patients presenting to tertiary Rhinology care with
moderate to severe allergic rhinitis symptoms. Screen-
ing lung function testing may be considered in this
patient population.
Jeffery et al. Journal of Otolaryngology - Head and Neck Surgery 2013, 42:58 Page 5 of 5
http://www.journalotohns.com/content/42/1/58Competing interests
The authors declare that they have no competing interests.Authors’ contributions
DWJC, EDW, MB, and HV conceived and designed the study. DWJC, EDW,
MB, HV, and CCJ collected the study data. CCJ analyzed the data and
prepared the manuscript. DWJC, EDW, MB, HV, HS, and CCJ approved the
final manuscript.
Author details
1Division of Otolaryngology-Head and Neck Surgery, Department of Surgery,
University of Alberta, 8440 112 Street, Edmonton, Alberta T6G 2B7, Canada.
2Division of Pulmonary Medicine, Department of Medicine, University of
Alberta, 8440 112 Street, Edmonton, Alberta T6G 2B7, Canada.
Received: 3 April 2013 Accepted: 3 September 2013
Published: 19 December 2013References
1. De Marco R, Cappa V, Accordini S, et al: Trends in the prevalence of
asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J
2012, 39:883–892.
2. Malik G, Tagiyeva N, Aucott L, et al: Changing trends in asthma in 9–12
year olds between 1964 and 2009. Arch Dis Child 2011, 96:227–231.
3. Duggan EM, Sturley J, Fitzgerald AP, et al: The 2002–2007 trends of
prevalence of asthma, allergic rhinitis and eczema in Irish
schoolchildren. Pediatr Allergy Immunol 2012, 23:464–471.
4. Keith PK, Desrosiers M, Laister T, Schellenberg RR, Waserman S: The burden
of allergic rhinitis (AR) in Canada: perspectives of physicians and
patients. Allergy Asthma Clin Immunol 2012, 8(1):7.
5. Bedouch P, Marra CA, FitzGerald JM, Lynd LD, Sadatsafavi M: Trends in
asthma-related direct medical costs from 2002 to 2007 in British
Columbia, Canada: a population based-cohort study. PLoS One 2012,
7(12):e50949.
6. Feng CH, Miller MD, Simon RA: The united allergic airway: connections
between allergic rhinitis, asthma, and chronic sinusitis. Am J Rhinol Allergy
2012, 26(3):187–190.
7. Guerra S, Sherrill DL, Martinez FD, Barbee RA: Rhinitis is an independent risk
factor for adult-onset asthma. J Allergy Clin Immunol. 2002, 109:419–425.
8. Tanaka A, Minoguchi K, Pawankar R, Adachi M: Asthma in patients with
Japanese cedar pollinosis. World Allergy Organ J 2012, 5(Suppl 3):S218–22.
9. Eriksson J, Bjerg A, Lotvall J, et al: Rhinitis phenotypes correlate with different
symptom presentation and risk factor patterns of asthma Respir Med 2011,
105:1611–1621.
10. Brozek JL, Bousquet J, Baena-Cagnani CE, et al: Allergic rhinitis and its impact
on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010,
126:466e76.
11. Marple BF: Allergic rhinitis and inflammatory airway disease: Interactions
within the unified airspace. Am J Rhinol Allergy 2010, 24:249–254.
12. Becky Kelly EA, Busse WW, Jarjour NN: A comparison of the airway
response to segmental antigen bronchoprovocation in atopic asthma
and allergic rhinitis. J Allergy Clin Immunol 2003, 111:79–86.
13. Ciebiada M, Cichocki P, Kasztalska K, et al: Orally exhaled nitric oxide in
patients with seasonal allergic rhinitis during natural pollen season. Am J
Rhinol Allergy 2012, 26:e32–e36.
14. Scichilone N, Sanico AM, Diemer FB, Horowitz E, Togias A: Symptom
tirggers in rhinitis and asthma. J Allergy Clin Immuol 1999, 103:S8.
15. Togias A: Mechanisms of nose-lung interaction. Allergy 1999, 54:95–105.
16. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, et al: Allergic
rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008, 63
(Suppl. 86):8.
17. van Cauwenberge P, Watelet J-B, van Zele T, Wang DY, Toskala E, et al: Does
rhinitis lead to asthma? Rhinology 2007, 45:112–121.
18. Demirjian M, Rumbyrt JS, Gowda VC, Klaustermeyer WB: Serum IgE and
eosinophil count in allergic rhinitis–analysis using a modified Bayes'
theorem. Allergol Immunopathol (Madr) 2012, 40(5):281–287.
19. Omenaas E, Bakke P, Elsayed S, Hanoa R, Gulsvik A: Total and specific
serum IgE levels in adults: relationship to sex, age and environmental
factors. Clin Exp Allergy 1994, 24(6):530–9.20. Wittig HJ, Belloit J, De Fillippi I, Royal G: Age-related serum
immunoglobulin E levels in healthy subjects and in patients with allergic
disease. J Allergy Clin Immunol 1980, 66(4):305.
21. Meltzer EO, Nathan R, Derebery J, Stang PE, Campbell UB, Yeh WS, Corrao
M, Stanford R: Sleep, quality of life, and productivity impact of nasal
symptoms in the United States: findings from the burden of rhinitis in
America survey. Allergy Asthma Proc 2009, 30(3):244.
22. Manfreda J, Becklake MR, Sears MR, et al: Prevalence of asthma symptoms
among adults aged 20–44 years in Canada. Can Med Assoc J. 2011,
164:995–1001.
23. Rosychuk RJ, Voaklander DC, Klassen TP, Senthilselvan A, Marrie TJ, Rowe
BH: A population-based study of emergency department presentations
for asthma in regions of Alberta. CJEM 2010, 12(4):339–46.
doi:10.1186/1916-0216-42-58
Cite this article as: Jeffery et al.: Association between allergic rhinitis
and asthma in a Northern Alberta cohort. Journal of Otolaryngology -
Head and Neck Surgery 2013 42:58.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
